Riverwater Partners · 2026 · Published 3 November 2026
Riverwater Partners argues that small caps, at about 19 times earnings against 29 for large caps, still trade at a discount while Russell 2000 earnings grew 33% over the past year, and that profitable small caps lagged mainly because of unprofitable biopharma stocks, outside which profitable companies returned 12.6% against 3.9%.
Riverwater compares its small-cap approach to the Milwaukee Brewers, who won the World Series with the 19th-largest payroll, about $146 million. On 29 July 2026 small caps traded at about 19 times earnings against 29 times for large caps, and at the end of September the S&P SmallCap 600 traded at about 80% of the S&P 500's multiple. Russell 2000 trailing earnings, after falling nearly 25% from late 2023, were about 13% above October 2023 levels by 30 September 2026, and grew 33% over the year while the index's multiple fell almost 14%. Profitable Russell 2000 companies lagged the index by about four points a year over 18 months, and the average small-cap core fund trailed by about 12 points. Over the year to 30 September, unprofitable stocks returned 19.9% against 14.8% for profitable ones, but without biopharma profitable companies returned 12.6% against 3.9%.